Nicolas Girard

17PUBLICATIONS
202CO-AUTHORS
Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Jun 23, 2026
Endomyocardial Biopsy in Suspected Immune Checkpoint Inhibitor-Myocarditis: Histologic Spectrum and Correlations With Clinical and Cardiac Magnetic Resonance Features.

|Mar 03, 2026
Nivolumab ± Ipilimumab in Patients With Pretreated Advanced Neuroendocrine Carcinoma: The GCO-001 NIPINEC Randomized Phase II Trial.

Thomas Pierre Walter, Julien Mazieres, Josiane Otto

|Oct 27, 2025
Altered Thymopoiesis in Thymoma Is Associated with Defects in Negative Selection Machinery and Decreased Treg Abundance.

Clémence Basse, Alexandre Lanau, Camille Kergaravat

|Oct 14, 2025
Ifinatamab Deruxtecan in Patients With Extensive-Stage Small Cell Lung Cancer: Primary Analysis of the Phase II IDeate-Lung01 Trial.

Charles M Rudin, Melissa L Johnson, Luis Paz-Ares

|May 08, 2025
Real-world treatment and outcomes for EGFR WT advanced/metastatic non-squamous non-small cell lung cancer: pooled analysis from project LUMINATE-101.

Nicolas Girard, Qingqing Xu, D Ross Camidge

|Jan 23, 2025
Pooled safety analysis and management of sotorasib-related adverse events in KRAS G12C-mutated advanced non-small cell lung cancer.

Ferdinandos Skoulidis, Bob T Li, Maximilian Hochmair

Pageof 3

Frequent Collaborators

5 joint publications

Shun Lu

3 joint publications

Enriqueta Felip

2 joint publications

Clémence Basse

2 joint publications

Oscar Juan-Vidal